
Boston Scientific has told the US Securities and Exchange Commission that a cybersecurity incident detected on 25 August has caused “a global disruption to the Company’s operations”, including its ability to process and ship customer orders. Shares fell about 3.5% in premarket trading, and the…
No discussion yet. Be the first to share your thoughts!